Drugs Made in America Acquisition (DMAAU) Competitors $10.12 -0.08 (-0.78%) As of 03:15 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends DMAAU vs. ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, ANSCU, and AITRUShould you be buying Drugs Made in America Acquisition stock or one of its competitors? The main competitors of Drugs Made in America Acquisition include A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), and AI Transportation Acquisition (AITRU). These companies are all part of the "trading" industry. Drugs Made in America Acquisition vs. A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition A SPAC III Acquisition (NASDAQ:ASPCU) and Drugs Made in America Acquisition (NASDAQ:DMAAU) are both finance, insurance, and real estate companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, community ranking, valuation and profitability. Which has higher valuation and earnings, ASPCU or DMAAU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioA SPAC III AcquisitionN/AN/AN/AN/AN/ADrugs Made in America AcquisitionN/AN/AN/AN/AN/A Does the media prefer ASPCU or DMAAU? In the previous week, Drugs Made in America Acquisition had 1 more articles in the media than A SPAC III Acquisition. MarketBeat recorded 3 mentions for Drugs Made in America Acquisition and 2 mentions for A SPAC III Acquisition. Drugs Made in America Acquisition's average media sentiment score of 0.57 beat A SPAC III Acquisition's score of 0.43 indicating that Drugs Made in America Acquisition is being referred to more favorably in the news media. Company Overall Sentiment A SPAC III Acquisition Neutral Drugs Made in America Acquisition Positive Does the MarketBeat Community favor ASPCU or DMAAU? A SPAC III Acquisition and Drugs Made in America Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformA SPAC III AcquisitionN/AN/ADrugs Made in America AcquisitionN/AN/A Is ASPCU or DMAAU more profitable? Company Net Margins Return on Equity Return on Assets A SPAC III AcquisitionN/A N/A N/A Drugs Made in America Acquisition N/A N/A N/A SummaryDrugs Made in America Acquisition beats A SPAC III Acquisition on 2 of the 2 factors compared between the two stocks. Get Drugs Made in America Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAAU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAAU vs. The Competition Export to ExcelMetricDrugs Made in America AcquisitionInvestment Offices IndustryFinance, Insurance, And Real Estate SectorNASDAQ ExchangeMarket CapN/A$113.30M$6.74B$8.30BDividend YieldN/AN/A2.15%3.97%P/E RatioN/AN/A2.3418.99Price / SalesN/AN/A18.16107.51Price / CashN/AN/AN/A34.62Price / BookN/AN/AN/A4.20Net IncomeN/AN/AN/A$246.82M7 Day Performance0.89%-1.21%-0.78%-4.63%1 Month Performance1.69%1.09%0.52%-7.79%1 Year PerformanceN/A1.43%2.82%2.41% Drugs Made in America Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAAUDrugs Made in America AcquisitionN/A$10.12-0.8%N/AN/A$0.00N/A0.002ASPCUA SPAC III AcquisitionN/A$10.15flatN/AN/A$0.00N/A0.00N/AAGBAWAGBA GroupN/A$0.15+8.2%N/A+511.1%$0.00$38.55M0.00152Gap DownAGNCPAGNC InvestmentN/A$25.27+0.1%N/A+7.2%$0.00$973M0.0050News CoverageAGNCOAGNC InvestmentN/A$25.570.0%N/A+5.8%$0.00$973M0.0050Short Interest ↓Positive NewsAGNCNAGNC InvestmentN/A$25.900.0%N/A+1.0%$0.00$973M0.0050Positive NewsAGNCMAGNC InvestmentN/A$25.33+0.0%N/A+2.5%$0.00$973M0.0050AGNCLAGNC InvestmentN/A$25.12-0.5%N/A+8.1%$0.00$973M0.0050Positive NewsANSCWAgriculture & Natural Solutions AcquisitionN/A$0.40+21.2%N/AN/A$0.00N/A0.00N/AGap DownHigh Trading VolumeANSCUAgriculture & Natural Solutions AcquisitionN/A$10.69+0.4%N/A+5.4%$0.00N/A0.00N/AGap UpAITRUAI Transportation AcquisitionN/A$10.80-3.6%N/AN/A$0.00N/A0.00N/AGap Down Related Companies and Tools Related Companies A SPAC III Acquisition Competitors AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors Agriculture & Natural Solutions Acquisition Competitors AI Transportation Acquisition Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DMAAU) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made in America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made in America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
